Immunohistochemistry (IHC) examining loss of expression (LOE) of one or more MMR proteins can be performed on adenomas as a screening test for LS, and subsequent genetic testing based on MMR IHC can ultimately confirm an LS diagnosis. The gene discussed is MRC1; the disease is Leigh syndrome.